Email Updates

You are here

Home

29 APRIL 2022 VOLUME 24 ISSUE 17

Media Coverage

  • Q&A: Start Talking About mRNA Vaccine Access Now, Say Experts

    While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world’s most neglected infectious diseases say that conversations about access should begin now. To explore the potential of mRNA vaccine technology to help the world tackle the three deadliest communicable diseases – tuberculosis, malaria, and HIV/AIDS – SciDev.Net spoke to two infectious diseases specialists, Rebecca Grais and Marie-Paule Kieny.

    April 29, 2022
    HIV Vaccine
    SciDev.Net

  • Buckle Up! The ‘Staley vs Gilead’ Lawsuit Could Cost Big Pharma Billions

    The latest twist in the Staley vs. Gilead lawsuit could signal very bad things for Gilead Sciences and Janssen Pharmaceuticals. As the case barrels forward (a jury date is set for March 2023), it could eventually cost Big Pharma billions of dollars in profits that the lawsuit contends has been the result of illegally shaking down people living with HIV and our insurers.

    April 28, 2022
    General
    POZ

  • The COVID-19 Pandemic Disrupted HIV Prevention and Care in Barcelona, but New Cases and Viral Loads Didn’t Increase

    In-person healthcare visits related to HIV prevention and care decreased in number at the largest HIV care centre in Spain as a result of lockdowns during the COVID-19 pandemic. While chlamydia and gonorrhoea cases surged in 2020 compared to 2019, new HIV cases decreased by 28 percent.

    April 28, 2022
    PrEP, Treatment
    aidsmap

  • Eastern Cape Youth Need Better Sex Education, User-Friendly Clinics and Easier Access to Contraception To Prevent HIV and Teen Pregnancies

    In her budget vote speech delivered on 15 March Eastern Cape Health MEC Nomakhosazana Meth expressed concern over the number of teenage pregnancies in the province. She called on young people to abstain from sex until they are at least 21 years old. But some health activists in the province believe a more comprehensive intervention is needed and are calling for a strategic plan to combat the high number of teenage pregnancies and HIV infections in young people.

    April 27, 2022
    Hormonal Contraceptives and HIV, PrEP
    Daily Maverick

  • Broadly Neutralizing Antibodies Delay HIV Rebound

    A combination of two broadly neutralizing antibodies (bnAbs) led to prolonged viral suppression after stopping HIV treatment, according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2022) and recently published in Nature. While this study was small, the findings suggest bnAbs could one day be a component of a combination HIV cure strategy.

    April 27, 2022
    Antibody Related Research
    POZ

  • Can mRNA Vaccine Tech Take on Tuberculosis?

    A successful mRNA vaccine for tuberculosis could be rapidly developed and save more than 1 million lives every year, say hopeful global health advocates. Researchers are pushing to capitalise on the success of mRNA technology against COVID-19 by exploring whether the platform could be effective against tuberculosis, the world’s second most deadly infectious disease.

    April 27, 2022
    General
    SciDev.Net

  • ‘The Devil You Know’: Many People Over 50 Are Taking Outdated ART, Despite Side Effects

    Three years ago, while speaking to a friend about his antiretroviral treatment (ART), I was alarmed to learn that he was still using efavirenz/emtricitabine/tenofovir (Atripla), even though he’d been living with HIV for over 10 years and there are better options available in the U.S. This friend was in his 60s at the time. He assured me that his doctor had decided that because he was doing well with efavirenz/emtricitabine/tenofovir—aside from occasional nightmares and becoming too sleepy to function—there was no reason to change.

    April 26, 2022
    Treatment
    The BodyPro

  • Test-and-Treat Leads to Sustained Fall in Hepatitis C in Swiss Gay Men With HIV

    Intensive screening for hepatitis C, treatment and risk reduction counselling have led to sustained declines in hepatitis C prevalence and new cases of hepatitis C among gay and bisexual men living with HIV in the Swiss HIV Cohort, researchers report in the journal Clinical Infectious Diseases.

    April 26, 2022
    General
    aidsmap

  • HIV Cure Research Lacks Diversity From the Earliest Stages, Scientists Warn

    Too many researchers working on a cure for HIV neglect to sample populations that represent people who are most affected by HIV, according to a recently published report from George Washington University. The authors reveal that only half of the scientific publications reviewed reported any demographic data from their study populations. “Given that the samples emerged from human participants, the lack of even the most basic information about sample demographic characteristics is striking,” the authors write.

    April 25, 2022
    Cure
    The BodyPro

  • Is It Really Possible to End HIV? An Australian State Nears That Goal

    For many cities and countries across the world, the goal of ending HIV by 2030 has been an aspirational yet unrealistic target. But the Australian state New South Wales (NSW) is close to accomplishing exactly that—and doing it by 2025.... Data show a total of only 178 new HIV cases in 2021 in NSW, which marks the lowest number on record and a 36 percent decrease over the previous five years.

    April 25, 2022
    General
    POZ

  • Amid Urban Outbreaks, Signs Point to HIV Spread in Rural West Virginia

    Last year, for the first time since 2015, West Virginia health officials detected HIV in rural Taylor County. And that county isn’t alone: as officials are still trying to get outbreaks in the state’s more urban areas under control, the virus is popping up in new places. New HIV cases were found in 29 West Virginia counties last year. For eight of those counties, it was the first case in recent years.

    April 23, 2022
    General
    The Register-Herald

  • The CDC Needs the Public’s Help To Reverse the Upward Trend in STIs

    Sexually transmitted infections have been on the rise in the United States for some time. In 2019, the country reached an all-time high for the sixth year in a row. Then COVID-19 struck and healthcare across the US was profoundly disrupted.

    April 22, 2022
    General
    Popular Science

  • Rebranded AIDS United Fund Looks to Harm Reduction’s Future

    Syringe service programs (SSP) in the United States began as acts of civil disobedience by drug users in the early days of the HIV crisis. Acts of love, for their friends and families and partners dying all around them. At the time, the “point” really was the point (to paraphrase the legendary Dave Purchase)—HIV prevention was a matter of life and death.

    April 22, 2022
    General
    Filter

Published Research

Announcements